ccdd_code,ccdd_formal_name,ccdd_type,policy_type,policy_reference,special_groupings_status,special_groupings_status_effective_time,changes
9015083,methylphenidate hydrochloride 5 mg per mL powder for prolonged-release oral suspension,NTP,500004,http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html,Active,20170919,ADDED
02541637,QUILLIVANT ER ORAL SUSPENSION (methylphenidate hydrochloride 5 mg per mL powder for prolonged-release oral suspension) KYE PHARMACEUTICALS INC.,MP,500004,http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html,Active,20170919,ADDED
02549794,PMS-MORPHINE SULFATE (morphine sulfate 5 mg oral tablet) PHARMASCIENCE INC,MP,500008,https://www.tppalberta.ca/medication-lists,Active,20240201,ADDED
02546264,SANDOZ LISDEXAMFETAMINE CAPSULES (lisdexamfetamine dimesylate 30 mg oral capsule) SANDOZ CANADA INCORPORATED,MP,500003,http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html,Active,20170919,ADDED
02549808,PMS-MORPHINE SULFATE (morphine sulfate 10 mg oral tablet) PHARMASCIENCE INC,MP,500008,https://www.tppalberta.ca/medication-lists,Active,20240201,ADDED
